Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Nippon Indosari Corpindo Tbk. (ROTI) vs Organon Pharma Indonesia Tbk. (SCPI)

Nippon Indosari Corpindo Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Nippon Indosari Corpindo Tbk. dan Organon Pharma Indonesia Tbk.: Nippon Indosari Corpindo Tbk. diperdagangkan di Rp585 (kapitalisasi pasar 3,62 T, volume 24 jam 583,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Nippon Indosari Corpindo Tbk. jauh lebih besar — sekitar 34,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

ROTISCPI
Kapitalisasi Pasar
3,62 T104,4 M
Volume
583,1 rb
Lot
5,83 rb
Perputaran
340,99 jt
Harga Rata-rata
584,79
Nilai Transaksi
340,99 jt
Harga Ekuilibrium Indikatif
585
Volume Ekuilibrium Indikatif
1,81 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ROTI
Lihat detail
SCPI
Lihat detail

Tentang Nippon Indosari Corpindo Tbk.

PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.

Selengkapnya di halaman ROTI

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI